Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions
BMAC
1 other identifier
interventional
17
1 country
1
Brief Summary
The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2013
CompletedFirst Posted
Study publicly available on registry
December 13, 2013
CompletedStudy Start
First participant enrolled
January 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2019
CompletedAugust 16, 2019
July 1, 2019
5.4 years
December 10, 2013
August 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pain Assessment
Visual Analog Scale (VAS)
pre-operative up to 2yrs post surgery
Change in Functional Assessment
Foot and Ankle Disability Index
pre-operative to 2yrs post surgery
Secondary Outcomes (3)
Change in Functional Assessment
pre-operative through 2yrs post surgery
Change in Functional Assessment
pre-operative through 2yrs post surgery
MRI Assessment
1 year post surgical intervention
Study Arms (2)
Microfracture
OTHERProcedure/Surgery: ankle arthroscopy with debridement and microfracture of the OLT
microfracture + injection of autologous BMAC
OTHERProcedure/Surgery: ankle arthroscopy with debridement and microfracture of the OLT plus injection of autologous Bone Marrow Aspirate Concentration
Interventions
ankle arthroscopy with debridement and microfracture of the OLT
Eligibility Criteria
You may qualify if:
- over age 18
- has an OLT that has not had previous surgical treatment
You may not qualify if:
- OLT greater than 1.5cm in diameter (these require more extensive treatment)
- more than one OLT
- radiographic evidence of widespread ankle joint arthritis
- any systemic inflammatory disease
- any ankle deformity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Medical Plaza Page Road
Durham, North Carolina, 27703, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Samuel B Adams, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 10, 2013
First Posted
December 13, 2013
Study Start
January 29, 2014
Primary Completion
June 26, 2019
Study Completion
June 26, 2019
Last Updated
August 16, 2019
Record last verified: 2019-07